
KarXT: A New Dawn in Antipsychotic Treatment
Psychopharmacology and Psychiatry Updates
00:00
Promising Results from CAR-XT Trial for Schizophrenia
This chapter explores the promising trial results of CAR-XT, a novel cholinergic antipsychotic for schizophrenia, which shows significant clinical efficacy and a unique side effect profile. It also discusses potential FDA approval and the broader implications for treating various symptoms of the disorder.
Transcript
Play full episode